Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation

Nandita D Khera, Yu Hui Chang, James L Slack, Veena Fauble, Jose F. Leis, Pierre Noel, Lisa Sproat, Jeanne Palmer, Roberta Adams, Tom Fitch, Donald W Northfelt, Mignonne Guy, Jon C Tilburt, Joseph R Mikhael

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Abstract Disparities in outcomes after hematopoietic cell transplant (HCT) are reported mostly by registry studies. We examined the association of self-reported race and ethnicity with outcomes and health care utilization after allogeneic HCT in a single center study. Clinical and socioeconomic data of 296 adult patients who underwent allogeneic HCT from November 2003 to October 2012 were analyzed. Survival was compared between non-Hispanic Whites (NHW) and minority patients using Cox proportional hazards regression. Some 73% of patients were NHW and 27% were racial/ethnic minority patients. More minority patients were younger and had lower socioeconomic status. Both unadjusted and adjusted overall and progression-free survival were comparable between the two groups. High risk disease, poor performance score and Medicare/Tricare were significant predictors of mortality. Health care utilization was comparable between the two groups. Homogeneity of medical care for allogeneic HCT may help overcome racial/ethnic disparities, but not those due to patients' primary insurance.

Original languageEnglish (US)
Pages (from-to)987-992
Number of pages6
JournalLeukemia and Lymphoma
Volume56
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Patient Acceptance of Health Care
Cell Transplantation
Transplants
Medicare
Insurance
Social Class
Disease-Free Survival
Registries
Survival
Mortality

Keywords

  • Disparities
  • Health care utilization
  • Hematopoietic cell transplant
  • Race/ethnicity

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation. / Khera, Nandita D; Chang, Yu Hui; Slack, James L; Fauble, Veena; Leis, Jose F.; Noel, Pierre; Sproat, Lisa; Palmer, Jeanne; Adams, Roberta; Fitch, Tom; Northfelt, Donald W; Guy, Mignonne; Tilburt, Jon C; Mikhael, Joseph R.

In: Leukemia and Lymphoma, Vol. 56, No. 4, 01.04.2015, p. 987-992.

Research output: Contribution to journalArticle

Khera, Nandita D ; Chang, Yu Hui ; Slack, James L ; Fauble, Veena ; Leis, Jose F. ; Noel, Pierre ; Sproat, Lisa ; Palmer, Jeanne ; Adams, Roberta ; Fitch, Tom ; Northfelt, Donald W ; Guy, Mignonne ; Tilburt, Jon C ; Mikhael, Joseph R. / Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation. In: Leukemia and Lymphoma. 2015 ; Vol. 56, No. 4. pp. 987-992.
@article{607c216949544cf2b80cca7e54988721,
title = "Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation",
abstract = "Abstract Disparities in outcomes after hematopoietic cell transplant (HCT) are reported mostly by registry studies. We examined the association of self-reported race and ethnicity with outcomes and health care utilization after allogeneic HCT in a single center study. Clinical and socioeconomic data of 296 adult patients who underwent allogeneic HCT from November 2003 to October 2012 were analyzed. Survival was compared between non-Hispanic Whites (NHW) and minority patients using Cox proportional hazards regression. Some 73{\%} of patients were NHW and 27{\%} were racial/ethnic minority patients. More minority patients were younger and had lower socioeconomic status. Both unadjusted and adjusted overall and progression-free survival were comparable between the two groups. High risk disease, poor performance score and Medicare/Tricare were significant predictors of mortality. Health care utilization was comparable between the two groups. Homogeneity of medical care for allogeneic HCT may help overcome racial/ethnic disparities, but not those due to patients' primary insurance.",
keywords = "Disparities, Health care utilization, Hematopoietic cell transplant, Race/ethnicity",
author = "Khera, {Nandita D} and Chang, {Yu Hui} and Slack, {James L} and Veena Fauble and Leis, {Jose F.} and Pierre Noel and Lisa Sproat and Jeanne Palmer and Roberta Adams and Tom Fitch and Northfelt, {Donald W} and Mignonne Guy and Tilburt, {Jon C} and Mikhael, {Joseph R}",
year = "2015",
month = "4",
day = "1",
doi = "10.3109/10428194.2014.941834",
language = "English (US)",
volume = "56",
pages = "987--992",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation

AU - Khera, Nandita D

AU - Chang, Yu Hui

AU - Slack, James L

AU - Fauble, Veena

AU - Leis, Jose F.

AU - Noel, Pierre

AU - Sproat, Lisa

AU - Palmer, Jeanne

AU - Adams, Roberta

AU - Fitch, Tom

AU - Northfelt, Donald W

AU - Guy, Mignonne

AU - Tilburt, Jon C

AU - Mikhael, Joseph R

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Abstract Disparities in outcomes after hematopoietic cell transplant (HCT) are reported mostly by registry studies. We examined the association of self-reported race and ethnicity with outcomes and health care utilization after allogeneic HCT in a single center study. Clinical and socioeconomic data of 296 adult patients who underwent allogeneic HCT from November 2003 to October 2012 were analyzed. Survival was compared between non-Hispanic Whites (NHW) and minority patients using Cox proportional hazards regression. Some 73% of patients were NHW and 27% were racial/ethnic minority patients. More minority patients were younger and had lower socioeconomic status. Both unadjusted and adjusted overall and progression-free survival were comparable between the two groups. High risk disease, poor performance score and Medicare/Tricare were significant predictors of mortality. Health care utilization was comparable between the two groups. Homogeneity of medical care for allogeneic HCT may help overcome racial/ethnic disparities, but not those due to patients' primary insurance.

AB - Abstract Disparities in outcomes after hematopoietic cell transplant (HCT) are reported mostly by registry studies. We examined the association of self-reported race and ethnicity with outcomes and health care utilization after allogeneic HCT in a single center study. Clinical and socioeconomic data of 296 adult patients who underwent allogeneic HCT from November 2003 to October 2012 were analyzed. Survival was compared between non-Hispanic Whites (NHW) and minority patients using Cox proportional hazards regression. Some 73% of patients were NHW and 27% were racial/ethnic minority patients. More minority patients were younger and had lower socioeconomic status. Both unadjusted and adjusted overall and progression-free survival were comparable between the two groups. High risk disease, poor performance score and Medicare/Tricare were significant predictors of mortality. Health care utilization was comparable between the two groups. Homogeneity of medical care for allogeneic HCT may help overcome racial/ethnic disparities, but not those due to patients' primary insurance.

KW - Disparities

KW - Health care utilization

KW - Hematopoietic cell transplant

KW - Race/ethnicity

UR - http://www.scopus.com/inward/record.url?scp=84929087144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929087144&partnerID=8YFLogxK

U2 - 10.3109/10428194.2014.941834

DO - 10.3109/10428194.2014.941834

M3 - Article

C2 - 25012944

AN - SCOPUS:84929087144

VL - 56

SP - 987

EP - 992

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 4

ER -